Og's
Long Island Spirits, LONG ISLAND SPIRITS, INC. — BAITING HOLLOW, NY
New York
About Og's
Og's is a vodka brand originating from New York and registered with the U.S. Alcohol and Tobacco Tax and Trade Bureau. The brand is classified as an 80 to 89 proof vodka spirit. According to TTB records, Og's maintains a single distinct product offering within the vodka category. The brand has received one total label approval from the TTB, with records indicating approval activity in 2025. As a New York-based vodka producer, Og's operates within the established spirits market and maintains compliance with federal labeling and classification standards. The brand's streamlined product portfolio and recent approval documentation indicate its presence in the contemporary vodka market. Further information regarding specific product characteristics, production methods, or distribution channels is not available from publicly accessible TTB registration data.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Og's VODKA 80-89 PROOF | Vodka 80-89 Proof | Approved | 2025-11-28 | Long Island Spirits, LONG ISLAND SPIRITS, INC. |
Page 1 of 1
Og's at a Glance
Og's has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2025-11-28 and 2025-11-28. Produced in New York.
All information sourced from public TTB records.
Are you the owner or distributor of Og's?
Claim this brand listing to update information or get featured. Contact [email protected].
Produced At
Long Island Spirits, Long Island Spirits, INC.Related Brands
- Svedka also from New York
- Three Olives also from New York
- New Amsterdam also from New York
- Recipe 21 also from New York
- 1911 Established also from New York
- Muscle also makes Vodka 80-89 Proof
- Veil also makes Vodka 80-89 Proof
- Heritage Distilling CO also makes Vodka 80-89 Proof
- Holla also makes Vodka 80-89 Proof
- A.M. Scott Distillery also makes Vodka 80-89 Proof
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.